REFERENCE
Zhou Z-G, Wang R-L, Yu K-L.Myocardial infarction following recombinant tissue plasminogen activator treatment for acute ischemic stroke: A dangerous complication. Chinese Medical Journal 125: 2775-2776, No. 15, 5 Aug 2012. Available from: URL: http://dx.doi.org/10.3760/cma.j.issn.0366-6999.2012.15.024 - China
Additional information
Key words
adverse reactions; drug-induced; Alteplase; Myocardial-infarction
An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage
Rights and permissions
About this article
Cite this article
Alteplase. React. Wkly. 1426, 7 (2012). https://doi.org/10.2165/00128415-201214260-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201214260-00020